Psychiatr. praxi 2019; 20(3): 120-124 [Neurol. praxi. 2019;20(3):214-218]

Treatment of depressive disorders in pain syndromes

MUDr. Martin Hýža
Psychiatrické oddělení, Fakultní nemocnice Ostrava
Katedra neurologie a psychiatrie, Lékařská fakulta, Ostravská univerzita, Ostrava

Comorbidity of depressive disorder and chronic pain is very common in clinical practice. It is connected to worse prognosis and
more severe symptoms of both of them. A recognition of depressive disorder is the most important as it is often manifested with
somatic symptoms only. Common neurobiological mechanisms clarify the effectivity of antidepressants and psychotherapy in
treatment of pain. Both noradrenergic and serotonergic effect is needed for analgesic effect, so the older tricyclic antidepressants
and newer dual antidepressants SNRI are used.

Keywords: depressive disorder, pain, antidepressants, psychotherapy

Published: October 11, 2019  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Hýža M. Treatment of depressive disorders in pain syndromes. Psychiatr. praxi. 2019;20(3):120-124.
Download citation

References

  1. Bair MJ, Robinson RL, Katon W, Kroenke K. Depression and Pain Comorbidity: A Literature Review. Archives of Internal Medicine 2003; 163(20): 2433-2445. Go to original source... Go to PubMed...
  2. Börsbo B, Peolsson M, Gerdle B. The Complex Interplay between Pain Intensity, Depression, Anxiety and Catastrophising with Respect to Quality of Life and Disability. Disability and Rehabilitation 2009; 31(19): 1605-1613. Go to original source... Go to PubMed...
  3. Coyne JC, Schwenk TL, Fechner-Bates S. Nondetection of Depression by Primary Care Physicians Reconsidered. General Hospital Psychiatry 1995; 17(1): 3-12. Go to original source... Go to PubMed...
  4. Drug Approval Package: Cymbalta (Duloxetine Hydrochloride). Dostupný na https://www.accessdata.fda.gov/drugsatfda_docs/nda/2004/021427_s000_Cymbalta.cfm.
  5. Fields HL. Pain Modulation: Expectation, Opioid Analgesia and Virtual Pain. Progress in Brain Research 2000; 122: 245-253. Go to original source... Go to PubMed...
  6. Fishbain DA, Cutler RB, Rosomoff HL, Rosomoff RS. Do Antidepressants Have an Analgesic Effect in Psychogenic Pain and Somatoformn Pain Disorder? A Meta-Analysis. Psychosomatic Medicine 1998; 60(4): 503-509. Go to original source... Go to PubMed...
  7. Fishbain DAR, Cutler R, Rosomoff HL, Rosomoff RS. Evidence-Based Data from Animal and Human Experimental Studies on Pain Relief with Antidepressants: A Structured Review. Pain Medicine 2000; 1(4): 310-316. Go to original source... Go to PubMed...
  8. Glombiewski JA, Hartwich-Tersek J, Rief W. Two Psychological Interventions Are Effective in Severely Disabled, Chronic Back Pain Patients: A Randomised Controlled Trial. International Journal of Behavioral Medicine 2010; 17(2): 97-107. Go to original source... Go to PubMed...
  9. Goesling J, Clauw DJ, Hassett AL. Pain and Depression: An Integrative Review of Neurobiological and Psychological Factors. Current Psychiatry Reports 2013; 15(12): 421. Go to original source... Go to PubMed...
  10. Greenough CG, Fraser RD. The effects of compensation on recovery from low-back pain injury. Spine 1989; 14(9): 947-955. Go to original source... Go to PubMed...
  11. Herman E, Černý M, Praško J. Poruchy nálady. In: Herman E, Praško J, Seifertová D. Konziliární psychiatrie. Praha: Medical Tribune 2007: 624.
  12. Hirakawa N, Tershner SA, Fields HL. Highly Delta Selective Antagonists in the RVM Attenuate the Antinociceptive Effect of PAG DAMGO. Neuroreport 1999; 10(15): 3125-3129. Go to original source... Go to PubMed...
  13. Innes SI. Psychosocial factors and their role in chronic pain: A brief review of development and current status. Chiropr Osteopat. 2005; 13: 6. Go to original source... Go to PubMed...
  14. Institute of Medicine: Relieving Pain in America, A Blueprint for Transforming Prevention, Care, Education, and Research. Dostupný na https://iprcc.nih.gov/sites/default/files/IOM_Pain_Report_508C.pdf.
  15. Katon W. Depression: Relationship to Somatization and Chronic Medical Illness. The Journal of Clinical Psychiatry 1984; 45(3 Pt 2): 4-12.
  16. Kessler RC, Birnbaum H, Bromet E, Hwang I, Sampson N, Shahly V. Age Differences in Major Depression: Results from the National Comorbidity Survey Replication (NCS-R). Psychological Medicine 2010; 40(2): 225-237. Go to original source... Go to PubMed...
  17. Leino P, Magni G. Depressive and Distress Symptoms as Predictors of Low Back Pain, Neck-Shoulder Pain, and Other Musculoskeletal Morbidity: A 10-Year Follow-up of Metal Industry Employees. Pain 1993; 53 (1): 89-94. Go to original source... Go to PubMed...
  18. Mika J, Zychowska M, Makuch W, Rojewska E, Przewlocka B. Neuronal and Immunological Basis of Action of Antidepressants in Chronic Pain - Clinical and Experimental Studies. Pharmacological Reports 2013: PR 65(6): 1611-21. Go to original source... Go to PubMed...
  19. Mohr P, Melicher T, Knytl P. Vortioxetin: přehled nového antidepresiva. Psychiatrie pro praxi 2016; 17 (1): 31-34. Go to original source...
  20. Okada, K, Murase K, Kawakita K. Effects of Electrical Stimulation of Thalamic Nucleus Submedius and Periaqueductal Gray on the Visceral Nociceptive Responses of Spinal Dorsal Horn Neurons in the Rat. Brain Research 1999; 834(1-2): 112-21. Go to original source... Go to PubMed...
  21. Panerai AE, Monza G, Movilia P, Bianchi M, Francucci BM, Tiengo M. A Randomized, within-Patient, Cross-over, Placebo-Controlled Trial on the Efficacy and Tolerability of the Tricyclic Antidepressants Chlorimipramine and Nortriptyline in Central Pain. Acta Neurologica Scandinavica 1990; 82(1): 34-38. Go to original source... Go to PubMed...
  22. Praško J. Diagnostika a léčba psychických poruch při chronické bolesti. In: Herman E, Praško J, Seifertová D. Konziliární psychiatrie. Praha: Medical Tribune 2007: 624 s.
  23. Raudenská J. Biopsychosociální model chronické nenádorové bolesti. Paliat. med. liec. bolest., 2012, 5(1): 27-29.
  24. Rowbotham MC, Reisner LA, Davies PS, Fields HL. Treatment Response in Antidepressant-Na?ve Postherpetic Neuralgia Patients: Double-Blind, Randomized Trial. The Journal of Pain: Official Journal of the American Pain Society 2005; 6(11): 741-46. Go to original source... Go to PubMed...
  25. Simons LE, Elman I, Borsook D. Psychological Processing in Chronic Pain: A Neural Systems Approach. Neuroscience and Biobehavioral Reviews 2014; 39 : 61-78. Go to original source... Go to PubMed...
  26. Sindrup SH, Otto M, Finnerup NB, a Jensen TS. Antidepressants in the Treatment of Neuropathic Pain. Basic & Clinical Pharmacology & Toxicology 2005; 96(6): 399-409. Go to original source... Go to PubMed...
  27. Slováčková B. Psychiatrická problematika u somaticky nemocných. In: Psychiatrie a pedopsychiatrie. Praha: Karolinum 2015: 648 s.
  28. Smith HS, Smith EJ, Smith BR. Duloxetine in the Management of Chronic Musculoskeletal Pain. Therapeutics and Clinical Risk Management 2012; 8: 267-277. Go to original source... Go to PubMed...
  29. Torta RGV, Munari J. Symptom Cluster: Depression and Pain. Surgical Oncology 2010; 19(3): 155-159. Go to original source... Go to PubMed...
  30. Vymětal J. Lékařská psychologie. Praha: Portál 2003: 400.
  31. Williams AC de C, Eccleston C, Morley S. Psychological Therapies for the Management of Chronic Pain (Excluding Headache) in Adults. The Cochrane Database of Systematic Reviews 2012; 11: CD007407. Go to original source... Go to PubMed...
  32. Zis P, Daskalaki A, Bountouni I, Sykioti P, Varrassi G, Paladini A. Depression and Chronic Pain in the Elderly: Links and Management Challenges. Clinical Interventions in Aging 2017; 12: 709-720. Go to original source... Go to PubMed...
  33. Zuena AR, Maftei D, Alem? GS, Dal Moro F, Lattanzi R, Casolini P, Nicoletti F. Multimodal Antidepressant Vortioxetine Causes Analgesia in a Mouse Model of Chronic Neuropathic Pain. Molecular Pain 2018; 14: 1744806918808987. Go to original source... Go to PubMed...




Psychiatry for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.